.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cerilliant
Cipla
Boehringer Ingelheim
Harvard Business School
Accenture
Fish and Richardson
UBS
Covington
Julphar

Generated: February 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: PCT/EP99/07417

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-003Mar 26, 2012RXYesNo➤ Sign Up➤ Sign UpYYCOMBO W/ OTHER ANTIRETROVIRALS FOR TX OF HIV-1 IN ANTIRETROVIRAL TX-EXPERIENCED PT 6 YEARS UP, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND OTHERANTIRETROVIRALS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-001Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpYYCOMBO W/ OTHER ANTIRETROVIRALS FOR TX OF HIV-1 IN ANTIRETROVIRAL TX-EXPERIENCED PT 6 YEARS UP, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND OTHERANTIRETROVIRALS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-001Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpYYTREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-001Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpYYIN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-EXPERIENCED ADULT PATIENTS, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO AN NNRTI AND OTHER ANTIRETROVIRAL AGENTS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-002Dec 22, 2010RXYesYes➤ Sign Up➤ Sign UpYYCOMBO W/ OTHER ANTIRETROVIRALS FOR TX OF HIV-1 IN ANTIRETROVIRAL TX-EXPERIENCED PT 6 YEARS UP, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND OTHERANTIRETROVIRALS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-002Dec 22, 2010RXYesYes➤ Sign Up➤ Sign UpYYTREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-002Dec 22, 2010RXYesYes➤ Sign Up➤ Sign UpYYIN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-EXPERIENCED ADULT PATIENTS, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO AN NNRTI AND OTHER ANTIRETROVIRAL AGENTS
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-003Mar 26, 2012RXYesNo➤ Sign Up➤ Sign UpYY
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-001Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpYY
Janssen R And DINTELENCEetravirineTABLET;ORAL022187-002Dec 22, 2010RXYesYes➤ Sign Up➤ Sign UpYY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist